We describe a 44-year-old woman with progressive headache, ataxia, and seizures in association with multifocal cerebral and cerebellar leukoencephalopathy, intracranial calcifications, and cysts. The cause of death was intracerebellar hemorrhage while taking warfarin. Pathologic features on biopsy included angiomatous-like blood vessels, intense gliosis, and Rosenthal fiber formation in the white matter. Genetic analyses did not identify any significant mutations in two candidate genes.

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000244470.06748.18DOI Listing

Publication Analysis

Top Keywords

leukoencephalopathy intracranial
8
intracranial calcifications
8
calcifications cysts
8
adult case
4
case leukoencephalopathy
4
cysts describe
4
describe 44-year-old
4
44-year-old woman
4
woman progressive
4
progressive headache
4

Similar Publications

Complication after carotid artery revascularization is mainly represented by stroke. Reversible cerebral vasoconstriction syndrome triggering by carotid artery revascularization is exceptional but it is an unrecognized aetiology of stroke. It could be associated with brain edema and henceforth, a posterior reversible encephalopathy syndrome can be confused with post-carotid artery revascularization cerebral hyperperfusion syndrome.

View Article and Find Full Text PDF
Article Synopsis
  • Antibody-drug conjugates are a new class of cancer treatments that are becoming more widely used, but they come with various toxicities and complications that need to be managed, especially in emergencies.
  • Common side effects include diarrhea, nausea, rash, and peripheral neuropathy, while severe conditions like interstitial lung disease and sinusoidal obstruction syndrome can pose serious health risks.
  • Rare but critical issues include cardiac effects, ocular problems, and tumor lysis syndrome, which require careful monitoring and prompt medical intervention.
View Article and Find Full Text PDF
Article Synopsis
  • - This study compares the effectiveness and safety of normal brain-sparing radiotherapy (NBS-RT) versus whole-brain radiotherapy (WBRT) in treating multiple brain metastases from non-small cell lung cancer (NSCLC) in 503 patients, focusing on treatment outcomes and leukoencephalopathy risks.
  • - The results showed no significant differences in intracranial control or overall survival between the two groups after around 11 months of follow-up, but patients receiving WBRT experienced a higher incidence of leukoencephalopathy compared to those treated with NBS-RT.
  • - The conclusion suggests that NBS-RT, when combined with systemic therapy, is equally effective but less toxic than WBRT in managing multiple brain
View Article and Find Full Text PDF

Background: Peak-width of skeletonized mean diffusivity (PSMD), a neuroimaging marker of cerebral small vessel disease (SVD), has shown excellent instrumental properties. Here, we extend our work to perform a biological validation of PSMD.

Methods: We included 396 participants from the Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia (MarkVCID-1) Consortium and three replication samples (Cohorts for Heart and Aging Research in Genomic Epidemiology = 6172, Rush University Medical Center = 287, University of California Davis Alzheimer's Disease Research Center = 567).

View Article and Find Full Text PDF

Background: New onset seizures in pregnancy and postpartum are considered eclampsia as the default diagnosis. Other causes, such as intracranial haemorrhage, subarachnoid haemorrhage, cerebral venous sinus thrombosis or acute ischaemic stroke, have a similar mode of presentation, but need prompt diagnosis and institution of specific measures to decrease the risk of mortality and morbidity. Neuroimaging plays an important role in providing a specific diagnosis and hence aids in proper management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!